DBA/2 mice immunized with leukemia-derived EVs rich in CD80 and CD86 demonstrated dramatically better survival when exposed to L1210 cells than when the mice were immunized with unaltered leukemia-derived EVs (196). Here, CD86 is linked to leukemia.